Inhibition of c-Yes induces differentiation of HT-29 human colon cancer stem cells through midbody elongation
Open Access
- 9 June 2016
- journal article
- research article
- Published by Springer Nature in Tissue Engineering and Regenerative Medicine
- Vol. 13 (3) , 261-269
Abstract
Recent research suggests that a small group of cells, named cancer stem cells (CSCs), is responsible for initiating tumor formation, recurrence, and metastasis. c-Yes, a proto-oncogene that is a subfamily of Src family kinase, is often activated in human colon cancer; this implicates c-Yes in the onset and progression of the disease. The objective of this study was to investigate the correlation between c-Yes and CSCs. We performed a sphere formation assay and reverse transcription-polymerase chain reaction for studying the differentiation of HT-29 human colon CSCs. To demonstrate the specific role of c-Yes in CSCs, we performed live cell microscopy and a cell cycle assay. These study shows, for the first time, that c-Yes is enriched in CD133+ CSCs, compared to their CD133− counterparts, and that c-Yes depletion in CD133+ cells induces cell differentiation. Moreover, c-Yes depletion was found to elongate the midbody and increase the proliferation doubling time. This also suggested that the misregulation of microtubules during chromosomal separation causes aneuploidy. Our results suggest that c-Yes may play a crucial role in initiating, maintaining, and driving the tumorigenic property of colon cancer.Keywords
This publication has 23 references indexed in Scilit:
- Cancer, stem cells and cancer stem cells: old ideas, new developmentsF1000 Medicine Reports, 2011
- Specific Oncogenic Activity of the Src-Family Tyrosine Kinase c-Yes in Colon Carcinoma CellsPLOS ONE, 2011
- Targeting Wnt Signaling in Colon Cancer Stem CellsClinical Cancer Research, 2011
- Cancer Stem Cells and Self-renewalClinical Cancer Research, 2010
- Therapeutic implications of colon cancer stem cellsWorld Journal of Gastroenterology, 2010
- Colon cancer stem cellsJournal of Molecular Medicine, 2009
- The Stem Cell Marker CD133 (Prominin-1) is Phosphorylated on Cytoplasmic Tyrosine-828 and Tyrosine-852 by Src and Fyn Tyrosine KinasesBiochemistry, 2009
- Characterization of a subpopulation of colon cancer cells with stem cell‐like propertiesInternational Journal of Cancer, 2008
- Stem Cells in Colon CancerClinical Colorectal Cancer, 2008
- A Critical Role of CD30 Ligand/CD30 in Controlling Inflammatory Bowel Diseases in MiceGastroenterology, 2008